Ascletis Pharma Inc. (HKG:1672)
Hong Kong
· Delayed Price · Currency is HKD 16.51
-0.17 (-1.02%)
Apr 29, 2026, 4:08 PM HKT
Ascletis Pharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -359.88 | -300.94 | -144.72 | -314.84 | -199.02 | Upgrade
|
| Depreciation & Amortization | 17.62 | 18.86 | 16.78 | 28.4 | 27.83 | Upgrade
|
| Other Amortization | - | 1.89 | 3.42 | 2.11 | 2.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.34 | -0.09 | 0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 10.58 | - | 55.19 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 25.25 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | -15.87 | -40.31 | 22.89 | 17.88 | Upgrade
|
| Stock-Based Compensation | - | 3 | 1.33 | 3.19 | 7.13 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -0 | -0 | -0.01 | 0.01 | Upgrade
|
| Other Operating Activities | -74.51 | -98.48 | -94.67 | -33.2 | 7.27 | Upgrade
|
| Change in Accounts Receivable | - | 5.28 | 18.44 | 29.74 | -26.99 | Upgrade
|
| Change in Inventory | - | -3.6 | -8.05 | -12.84 | -5.07 | Upgrade
|
| Change in Accounts Payable | - | -0.62 | -2.49 | 2.08 | 0.12 | Upgrade
|
| Change in Unearned Revenue | - | -1.59 | -1.59 | -1.59 | -2.61 | Upgrade
|
| Change in Other Net Operating Assets | - | 14.31 | 28.14 | 16.41 | 24.37 | Upgrade
|
| Operating Cash Flow | -416.78 | -341.58 | -223.8 | -202.46 | -146.93 | Upgrade
|
| Capital Expenditures | - | -2.1 | -6.21 | -7.07 | -4.97 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.12 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.05 | -12.95 | -7.24 | -2.23 | Upgrade
|
| Investment in Securities | 580.1 | 853.84 | 160.73 | -1,137 | -269.78 | Upgrade
|
| Other Investing Activities | 82.08 | 127.22 | 87.78 | 3.32 | 2.48 | Upgrade
|
| Investing Cash Flow | 662.18 | 978.91 | 229.48 | -1,148 | -274.49 | Upgrade
|
| Long-Term Debt Repaid | - | -4.73 | -2.39 | -2.22 | -2.28 | Upgrade
|
| Net Debt Issued (Repaid) | - | -4.73 | -2.39 | -2.22 | -2.28 | Upgrade
|
| Issuance of Common Stock | 428 | - | - | 0.96 | - | Upgrade
|
| Repurchase of Common Stock | - | -98.53 | -78.96 | - | -28.69 | Upgrade
|
| Other Financing Activities | -82.77 | -0.24 | -0.14 | -0.16 | -0.13 | Upgrade
|
| Financing Cash Flow | 345.23 | -103.51 | -81.5 | -1.42 | -31.1 | Upgrade
|
| Foreign Exchange Rate Adjustments | -11.44 | 0.39 | 2.16 | 28.62 | -30.57 | Upgrade
|
| Net Cash Flow | 579.19 | 534.21 | -73.65 | -1,324 | -483.09 | Upgrade
|
| Free Cash Flow | -416.78 | -343.67 | -230.01 | -209.53 | -151.9 | Upgrade
|
| Free Cash Flow Margin | -20551.08% | -26786.75% | -406.40% | -387.38% | -197.59% | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.34 | -0.21 | -0.19 | -0.14 | Upgrade
|
| Cash Interest Paid | - | 0.24 | 0.14 | 0.16 | 0.13 | Upgrade
|
| Levered Free Cash Flow | -298.3 | -208.35 | -131.07 | -114.01 | -111.93 | Upgrade
|
| Unlevered Free Cash Flow | -298.2 | -208.2 | -130.98 | -113.91 | -111.86 | Upgrade
|
| Change in Working Capital | - | 13.79 | 34.45 | 33.81 | -10.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.